<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="./datadict_v2.xsl"?><data_table id="pht003743.v1" study_id="phs000715.v1" participant_set="1" date_created="Thu Mar 13 12:36:12 2014"><variable id="phv00200444.v1"><name>Specimen</name><description>These numbers are the sample/subject numbers assigned by the collecting brain banks.</description><type/><comment>Colorado-A and B specimens were identified and provided by Greg Owens, University of Colorado.</comment></variable><variable id="phv00200445.v1"><name>Consent</name><description>Consent group</description><type/><value code="1">General Research Use (GRU)</value></variable><variable id="phv00200446.v1"><name>Subject_Source</name><description>UCLA: Human Brain and Spinal Fluid Resource Center, VA Los Angeles, 11301 Wilshire Blvd., Los Angeles, CA 90073; Rocky Mountain MS Center, 701 E. Hampden Ave. Suite 420, Englewood, CO 80113; Greg Owens, University of Colorado.</description><type/></variable><variable id="phv00200447.v1"><name>Source_SubjID</name><description>IDs used at tissue source.</description><type/></variable><variable id="phv00200448.v1"><name>Affection Status</name><description>The assigned group: primary progressive MS (as identified by the brain bank source), NMO, normal control, or encephalitis. All group designations were assigned by the brain banks.</description><type/><value code="PPMS">Primary Progressive MS</value><value code="PPMS/NMO">Primary Progressive MS/Neuromyelitis Optica</value></variable></data_table>
